share_log

以岭药业:中药创新药藿夏感冒颗粒临床试验申请注册获得批准

Eling Pharmaceutical: Application for clinical trial registration of innovative Chinese medicine, Agaricus cold granules, has been approved

Breakings ·  Feb 1, 2023 16:42
Eling Pharmaceutical announced that the application for clinical trial registration of the innovative Chinese medicine Agaricus cold granules has been approved. Ageratum cold granules are traditional Chinese medicine compound preparations. The proposed functional treatment is to detoxify and relieve moisture. It is used for gastrointestinal colds and wind attacks. Symptoms include fever, bad wind, nasal congestion and runny nose, headache and drowsiness, nausea and vomiting, diarrhea, severe physical distress, abdominal pain, and poor eating.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment